AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
18.95
+0.30 (1.61%)
At close: Mar 28, 2025, 4:00 PM
19.04
+0.09 (0.48%)
After-hours: Mar 28, 2025, 7:55 PM EDT
AnaptysBio Market Cap
AnaptysBio has a market cap or net worth of $581.14 million as of March 28, 2025. Its market cap has decreased by -12.06% in one year.
Market Cap
581.14M
Enterprise Value
565.23M
1-Year Change
-12.06%
Ranking
Category
Stock Price
$18.95
Market Cap Chart
Since January 26, 2017, AnaptysBio's market cap has increased from $308.70M to $581.14M, an increase of 88.25%. That is a compound annual growth rate of 8.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 581.10M | 44.23% |
| Dec 31, 2024 | 402.90M | -29.22% |
| Dec 29, 2023 | 569.20M | -35.40% |
| Dec 30, 2022 | 881.10M | -7.83% |
| Dec 31, 2021 | 955.90M | 62.57% |
| Dec 31, 2020 | 588.00M | 33.36% |
| Dec 31, 2019 | 440.90M | -74.16% |
| Dec 31, 2018 | 1.71B | -27.90% |
| Dec 29, 2017 | 2.37B | 666.67% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |